![Bent Frandsen](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Bent Frandsen
Algemeen Directeur bij
EXPRES2ION BIOTECH HOLDING AB
Profiel
Bent U.
Frandsen currently works at ExpreS2ion Biotechnologies ApS, as Chief Executive Officer and Expres2ion Biotech Holding AB, as Chief Executive Officer from 2019.
Mr. Frandsen also formerly worked at Adaptvac ApS, as Director and NsGene A, as Vice President-Business Development.
Mr. Frandsen received his graduate degree in 1993 from Copenhagen Business School.
Actieve functies van Bent Frandsen
| Bedrijven | Functie | Begin |
|---|---|---|
| EXPRES2ION BIOTECH HOLDING AB | Algemeen Directeur | 20-12-2019 |
ExpreS2ion Biotechnologies ApS
 ExpreS2ion Biotechnologies ApS BiotechnologyHealth Technology Operates as a biotech company which engages in the field of protein production in Drosophila Schneider-2 cells | Algemeen Directeur | - |
Eerdere bekende functies van Bent Frandsen
| Bedrijven | Functie | Einde |
|---|---|---|
NsGene A/S
 NsGene A/S Pharmaceuticals: MajorHealth Technology Provides therapeutic products for the treatment of neurodegenerative disorders | Corporate Officer/Principal | - |
Adaptvac ApS
 Adaptvac ApS BiotechnologyHealth Technology Develops therapeutic and prophylactic vaccines | Directeur/Bestuurslid | - |
Opleiding van Bent Frandsen
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
60
Eerstegraads connecties
5
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 5 |
|---|---|
Copenhagen Business School
 Copenhagen Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
NsGene A/S
NsGene A/S Pharmaceuticals: MajorHealth Technology Provides therapeutic products for the treatment of neurodegenerative disorders | Health Technology |
ExpreS2ion Biotechnologies ApS
ExpreS2ion Biotechnologies ApS BiotechnologyHealth Technology Operates as a biotech company which engages in the field of protein production in Drosophila Schneider-2 cells | Health Technology |
Expres2ion Biotech Holding AB
 Expres2ion Biotech Holding AB BiotechnologyHealth Technology Engages in the development of a portfolio of vaccines for diseases such as COVID-19, influenza, and breast cancer | Health Technology |
Adaptvac ApS
Adaptvac ApS BiotechnologyHealth Technology Develops therapeutic and prophylactic vaccines | Health Technology |
